SuperworthChemed EPS CHE
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Jun 30, 2026
- $19.92
- Latest quarter, Q2 FY26
- $5.13
- +44% on a year earlier
- Fiscal year 2025
- $18.38
- −8% on the year before
Chemed's earnings per share was $19.92 over the twelve months to Jun 30, 2026, up 2% on a year earlier.
In its latest quarter, Q2 FY26, it was $5.13, up 44% on the same quarter a year before.
Over the five fiscal years to FY2025 it shrank 1% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $18.38 | −8% |
| FY2024 | $19.92 | +11% |
| FY2023 | $17.92 | +8% |
| FY2022 | $16.53 | −2% |
| FY2021 | $16.88 | −13% |
| FY2020 | $19.49 | +47% |
| FY2019 | $13.30 | +9% |
| FY2018 | $12.24 | +110% |
| FY2017 | $5.83 | −10% |
| FY2016 | $6.49 | +3% |
| FY2015 | $6.32 | +13% |
| FY2014 | $5.58 | +34% |
| FY2013 | $4.16 | −10% |
| FY2012 | $4.62 | +12% |
| FY2011 | $4.13 | +16% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $5.13 | +44% | $19.92 | |
| Q1 FY26 | $4.84 | −0% | $18.36 | |
| Q4 FY25 | $5.49 | −9% | $18.38 | |
| Q3 FY25 | $4.46 | −11% | $18.92 | |
| Q2 FY25 | $3.57 | −23% | $19.46 | |
| Q1 FY25 | $4.86 | +15% | $20.54 | |
| Q4 FY24 | $6.03 | +2% | $19.92 | |
| Q3 FY24 | $5.00 | +1% | $19.79 | |
| Q2 FY24 | $4.65 | +32% | $19.72 | |
| Q1 FY24 | $4.24 | +18% | $18.58 | |
| Q4 FY23 | $5.90 | +43% | $17.92 | |
| Q3 FY23 | $4.93 | +30% | $16.15 |
Against its peers
Companies in Medical - Care Facilities nearest Chemed's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| CHEChemed | $19.92 | +2% a year |
| PACSPACS | $1.75 | +113% a year |
| SHCSotera Health | $0.57 | +613% a year |
| CONConcentra Group Holdings Parent | $1.54 | +29% a year |
| LFSTLifeStance Health | $0.13 | |
| OPCHOption Care Health | $1.33 | +6% a year |
| ENSGEnsign | $6.38 | +16% a year |
| UHSUniversal Health Services | $24.55 | +29% a year |
| DVADavita | $12.22 | +20% a year |
| BTSGBrightSpring Health Services | $1.65 | +432% a year |
| NHCNational Healthcare | $8.89 | +32% a year |
| Peer median | $1.70 |
Where Chemed ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Chemed
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.